SchousboeLP. Otitis media with effusion is an inflammatory condition. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:245.
2.
MaxwellKLeonardGKreutzerDL. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg1997;123:984–8.
3.
BallSSPrazmaJDaisCG. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann Otol Rhinol Laryngol1997;106:633–9.
4.
StorgaardMLarsenKBlegvadS. Interleukin-8 and chemotactic activity of middle ear effusions. J Infect Dis1997;175:474–7.
5.
NassifPSSimpsonSQIzzoAA. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope1997;107:1223–7.
6.
ChonmaitreeTPatelJGarofaloR. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol1996;105:968–74.
7.
HeikkinenTGhaffarFOkoroduduAO. Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics1998;102:296–9.
8.
PitkarantaAHoviTKarmaP. Interferon production by leukocytes in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol1996;34:25–33.
9.
HebdaPAAlperCMDoyleWJ. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol1998;107:501–8.
10.
MelhusÅRyanAF. Competitive PCR for cytokine genes during experimental otitis media. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:69.
11.
RyanAFLuoL. Expression of nitric oxide synthase in the mouse middle ear mucosa during immune-mediated chronic otitis media. In: TosMThomasenJBalleV, eds. Otitis media today. Amsterdam, the Netherlands: Kugler, 1999:175–9.
12.
KuronoYHironoTWatanabeT. The role of IL-1 beta in murine model of otitis media with effusion. J Otorhinolaryngol Soc Japan1998;101:1093–8.
13.
YoshiokaIHimiTKatauraA. In vivo induction and regulation of interleukin-8-like chemokine GRO/CINC-1 in rat middle ear. Acta Otolaryngol (Stockh)1997;117:719–23.
14.
JohnsonMLeonardGKreutzerDL. Murine model of interleukin-8-induced otitis media. Laryngoscope1997;107:1405–8.
15.
FurukawaMKuboNYamashitaT. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Laryngoscope1995;105:188–91.
16.
OhnoYOhashiYSugiuraY. Effect of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig. Ann Otol Rhinol Laryngol1998;107:876–84.
17.
RheeCGParkYSLongSA. Effects of platelet activating factor on vascular permeability of the middle ear mucosa. Ann Otol Rhinol Laryngol1997;106:604–7.
18.
OndreyFGJuhnSKAdamsGL. Early-response cytokine expression in adult middle ear effusions. Otolaryngol Head Neck Surg1998;119:342–5.
19.
TachibanaFShimadaTHoriY. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute exacerbation. Auris Nasus Larynx1996;23:20–5.
20.
SwartsJDWestcottJYChanKH. Eicosanoid synthesis and inactivation in healthy and infected chinchilla middle ears. Acta Otolaryngol (Stockh)1997;117:845–50.
21.
CooterMSEismaRJBurlesonJA. Transforming growth factor–β expression in otitis media with effusion. Laryngoscope1998;108:1066–70.
22.
OehlHRyanA. Expression of genes encoding growth factor receptors in the middle ear mucosa. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:70.
23.
RyanAFOehlHMelhusÅ. Influence of growth factors on the middle ear mucosa. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:74.
24.
RyanAFLuoLBairdA. Implantation of cells transfected with the FGF-1 gene induces middle ear mucosal proliferation. In: LimDJBluestoneCDCasselbrantM, eds. Recent advances in otitis media. Proceedings of the Sixth International Symposium. Hamilton, Canada: BC Decker, 1996:248–50.
25.
MelhusÅRyanAF. Molecular markers for bone formation during bacterial otitis media in the rat. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:248.
26.
MondainMRyanAF. Epidermal growth factor and basic fibroblast growth factor are induced in guinea pig tympanic membrane following traumatic perforation. Acta Otolaryngol (Stockh)1995;115:50–4.
27.
MondainMRenardNRyanAF. Neutralizing antibodies against basic fibroblast growth factor influence the healing of traumatic tympanic membrane perforations. J Otorhinolaryngol1995;57:28–32.
28.
Narkio-MakelaMMeriS. Expression of protectin (CD59), an inhibitor of the membrane attack complex of complement in otitis media with effusion. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:78.
29.
JohnEONamGHJungTTK. Concentration of nitric oxide in middle ear effusion. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:83.
30.
JenningsCRCollinsHMGuoL. The analysis of middle ear effusion for matrix metalloproteinases 2 and 9. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:84.
31.
LiWLinJAdamsG. Effect of cytokines on iNOS expression of middle ear epithelial cells. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:86.
32.
ParksRRHuangCCHaddadJ. Superoxide dismutase in animal model of otitis media. Eur Arch Otorhinolaryngol1995;252:153–8.
33.
BallSSPrazmaJDaisD. Nitric oxide: Mediator of endotoxin-induced middle ear effusions. Laryngoscope1996;106:1021–7.
34.
RoseASPrazmaJRandellSH. Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg1997;116:308–16.
35.
ParkYSRoweMRKimPD. Effect of inhibitors of leukotriene and/or platelet-activating factor on experimental otitis media with effusion. In: LimDJ, ed. Abstracts of the Seventh International Symposium in Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:103.
36.
SutbeyazYYakanBOzdemirH. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol1996;105:476–80.
37.
LinJJuhnSKAdamsGL. Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. Acta Otolaryngol (Stockh)1997;117:406–13.
38.
TanakaTKuronoYKawauchiH. Effect of oxatomide on otitis media with effusion — An experimental study. Acta Otolaryngol (Stockh)1995;115:532–8.
39.
EnomotoFIchikawaGNagaokaI. Evaluation of the effect of erythromycin on otitis media with effusion in experimental rat models. J Otorhinolaryngol Soc Jpn1996;99:1126–35.
40.
BujiaJKimCOstos-AumenteP. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas. Eur Arch Otorhinolaryngol1997;254:6–8.
41.
ShiwaMKojimaHMoriyamaH. Expression of transforming growth factor–α (TGF-α) in cholesteatoma. J Laryngol Otol1998;112:750–4.
42.
BujiaJKimCBoyleD. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope1996;106:217–20.
43.
KimCSLeeCHChungJW. Interleukin-1α, interleukin-1β, and interleukin-8 gene expression in human aural cholesteatomas. Acta Otolaryngol (Stockh)1996;116:302–6.
44.
BujiaJKimCOstos-AumenteP. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol1996;253:152–7.
45.
AmarMSWishahiHFZakharyMM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol1996;110:534–9.
46.
ParkKHChunYMLeeDH. Signal transduction pathway in human middle ear cholesteatoma. Otolaryngol Head Neck Surg1999;120:899–904.
47.
SudhoffHDazertSGonzalesAM. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol2000;21:793–8.
48.
AlbinoAPReedJABogdanyJK. Expression of P53 protein in human middle ear cholesteatomas: Pathogenetic implications. Am J Otol1998;19:30–6.
49.
Smith-VaughanHCSriprakashKSMathewsJD. Nonencapsulated Haemophilus influenzae in Aboriginal infants with otitis media: Prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer. Infect Immun1997;65:1468–74.
50.
St GemeJWIIIKumarVVCutterD. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect Immun1998;66:364–8.
51.
St GemeJWIIIGrassS. Secretion of the Haemophilus influenzae HMW1 and HMW2 adhesins involves a periplasmic intermediate and requires the HMWB and HMWC proteins. Mol Microbiol1998;27:617–30.
52.
El-AdhamiWKydJMBastinDA. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect Immun1999;67:1935–42.
53.
DawidSBarenkampSJSt GemeJWIII. Variation in expression of the Haemophilus influenzae HMW adhesins: A prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A1999;96:1077–82.
54.
RenZJinHMortonDJ. hgpB, a gene encoding a second Haemophilus influenzae hemoglobin- and hemoglobin-haptoglobin-binding protein. Infect Immun1998;66:4733–41.
55.
WeiserJNMarkiewiczZTuomanenEI. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun1996;64:2240–5.
56.
SwiatloEBrooks-WalterABrilesDE. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae. Gene1997;188:279–84.
57.
AebiCCopeLDLatimerJL. Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis. Infect Immun1998;66:540–8.
58.
DuRPWangQYangYP. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect Immun1998;66:3656–65.
59.
BonnahRAWongHLoosmoreSM. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants. Infect Immun1999;67:1517–20.
60.
LukeNRRussoTALutherN. Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6. Infect Immun1999;67:681–7.
61.
ChunYMLimDJ. Mucin gene expression in the immortalized human middle ear epithelial cells. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:257.
62.
MoonSKYoonJHLeeHK. Effects of retinoic acid, triiodothyronine and hydrocortisone on mucin and lysozyme expression in passage-2 normal human middle ear epithelial cells. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:252.
63.
SoneMPaparellaMMSchachernPA. Expression of glycoconjugates in human eustachian tubes with otitis media. Laryngoscope1998;108:1474–9.
64.
HuttonDAFoggFJKubbaH. Heterogeneity in the protein cores of mucins isolated from human middle ear effusions: Evidence for expression of different mucin gene products. Glycoconjugate J1998;15:283–91.
65.
JungHHLeeJHLimHH. Expression of mucin genes in otitis media. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:251.
66.
SevernTLHuttonDABirchallJP. Mucin gene expression in human middle ear. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:253.
67.
LiJDXuHWangB. Signal transduction mechanisms involved in bacteria-induced mucin overproduction. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:77.
68.
LiJDFengWJGallupM. Activation of NF-kB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for P aeruginosa–induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A1998;95:5718–23.
69.
XuHWangBKimJH. Oxygen radicals as second messengers for bacteria-induced up-regulation of mucin gene transcription. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:255.
70.
LinJKawanoHTsuboiY. Alterations of mucin gene expression in the transition of acute to mucoid otitis media. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:72.
71.
DeFiore-HyrmerJBakaletzLO. Evidence obtained by confocal microscopy that links phosphorylation of tyrosine with nontypeable Haemophilus influenzae adherence and actin nucleation. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:175.
72.
HuangCCChenCTHuangTS. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein. Eur Arch Otorhinolaryngol1996;253:385–9.
73.
IshibashiTShinogamiMKagaK. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Acta Otolaryngol (Stockh)1997;117:714–8.
74.
ShinodaHHuangCC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: Relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope1995;105:1232–7.
75.
SchillingVLangSRaspG. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis. Acta Otolaryngol (Stockh)1996;116:741–6.
76.
ParkKParkHJChunYM. Expression of PLC-gamma 1 in experimental cholesteatoma. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:80.
77.
BikhaziPLuoLRyanAF. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope1995;105:629–34.
78.
ChunYMLiJDLimDJ. MEK1/2-MAPK pathway is involved in IL-1-induced down-regulation of surfactant B. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:256.
79.
JuhnSLiWFlaaganJ. Inflammatory NO involvement in auditory function. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:88.
80.
UshikaiMTakakiMMiyanoharaT. The role of the transcription factor NF-κB in the expression of IL-8 from human adenoidal fibroblasts. In: LimDJ, ed. Abstracts of the Seventh International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 1999:117.
81.
MalloM. Retinoic acid disturbs mouse middle ear development in a stage-dependent fashion. Dev Biol1997;184:175–86.
82.
MalloM. Embryological and genetic aspects of middle ear development. Int J Dev Biol1998;42:11–22.
83.
ZhuCCYamadaGBlumM. Correlation between loss of middle ear bones and altered goosecoid gene expression in the branchial region following retinoic acid treatment of mouse embryos in vivo. Biochem Biophys Res Commun1997;235:748–53.
84.
OttTKaestnerKHMonaghanAP. The mouse homolog of the region specific homeotic gene spalt of Drosophila is expressed in the developing nervous system and in mesoderm-derived structures. Mech Devel1996;56:117–28.
85.
ten BergeDBrouwerAKorvingJ. Prx1 and Prx2 in skeletogenesis: Roles in the craniofacial region, inner ear and limbs. Development1998;125:3831–42.
86.
TakeuchiKTsubouchiMMajimaY. Gammadelta T cell receptor repertoire in middle ear effusions in children. Acta Otolaryngol (Stockh)1998;118:563–6.
87.
MondainMRestituitoSVincentiV. Adenovirus-mediated in vivo gene transfer in guinea pig middle ear mucosa. Hum Gene Ther1998;9:1217–21.
88.
DazertSAletseeCBrorsD. In vivo adenoviral transduction of the neonatal rat cochlea and middle ear. Hear Res2001;151:30–40.